A Randomized controlled trial of Kalmegh onNon Alcoholic Fatty Liver Disease.
Phase 3
- Conditions
- Health Condition 1: E65- Localized adiposity
- Registration Number
- CTRI/2021/10/037692
- Lead Sponsor
- Department of community medicine INSTITUTE OF MEDICAL SCIENCES BANARAS HINDU UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient giving consent to participate in the study.
2..Adult Population of age group 18-60yrs attending Gastroenterology OPD
3.Patient with simple fatty liver
Patient with Non-Alcoholic SteatoHepatitis.
4.Patient with Non-Alcoholic SteatoHepatitis and fibrosis of STAGE -I and STAGE-II
Exclusion Criteria
1.Patient having Diabetes Mellitus.
2.Patient with alcoholic addiction.
3.Patient with NASH and fibrosis of STAGE-3.
4.Patient with liver cirrhosis.
5.Patient with severe obesity.
6.Patient not giving consent to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method